Synopsys, Inc. (NASDAQ:SNPS) Shares Acquired by Siemens Fonds Invest GmbH

Siemens Fonds Invest GmbH lifted its holdings in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 17.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,795 shares of the semiconductor company's stock after purchasing an additional 1,288 shares during the quarter. Siemens Fonds Invest GmbH's holdings in Synopsys were worth $4,269,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. James Hambro & Partners LLP increased its holdings in Synopsys by 30.9% in the 4th quarter. James Hambro & Partners LLP now owns 201,460 shares of the semiconductor company's stock worth $97,725,000 after buying an additional 47,527 shares during the period. Fiera Capital Corp lifted its position in shares of Synopsys by 33.8% in the fourth quarter. Fiera Capital Corp now owns 196,391 shares of the semiconductor company's stock valued at $95,320,000 after acquiring an additional 49,653 shares in the last quarter. Bancreek Capital Management LP purchased a new stake in shares of Synopsys during the fourth quarter worth $3,827,000. Meridiem Investment Management Ltd. raised its holdings in Synopsys by 13.1% in the 4th quarter. Meridiem Investment Management Ltd. now owns 557,174 shares of the semiconductor company's stock valued at $270,322,000 after acquiring an additional 64,322 shares during the last quarter. Finally, Symphony Financial Ltd. Co. increased its holdings in shares of Synopsys by 156.4% in the fourth quarter. Symphony Financial Ltd. Co. now owns 1,059 shares of the semiconductor company's stock valued at $569,000 after purchasing an additional 646 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company's stock.

Synopsys Stock Down 1.6%

NASDAQ SNPS traded down $7.44 during mid-day trading on Thursday, hitting $454.99. The stock had a trading volume of 4,314,126 shares, compared to its average volume of 1,134,829. The company has a market cap of $70.35 billion, a price-to-earnings ratio of 31.34, a P/E/G ratio of 3.23 and a beta of 1.16. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $624.80. The company has a 50 day simple moving average of $453.45 and a 200 day simple moving average of $487.42.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings results on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share for the quarter, topping analysts' consensus estimates of $3.40 by $0.27. Synopsys had a return on equity of 20.48% and a net margin of 36.12%. The company had revenue of $1.60 billion during the quarter, compared to analysts' expectations of $1.60 billion. During the same period in the previous year, the firm posted $3.00 earnings per share. The business's revenue for the quarter was up 10.3% compared to the same quarter last year. As a group, equities analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insider Activity at Synopsys

In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the sale, the chief executive officer now owns 70,922 shares of the company's stock, valued at approximately $32,890,077.50. The trade was a 13.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Geus Aart De sold 15,705 shares of Synopsys stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $444.42, for a total value of $6,979,616.10. Following the sale, the insider now directly owns 116,671 shares in the company, valued at approximately $51,850,925.82. The trade was a 11.86% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.62% of the company's stock.

Analysts Set New Price Targets

A number of research firms recently commented on SNPS. Morgan Stanley decreased their price objective on Synopsys from $625.00 to $590.00 and set an "overweight" rating on the stock in a report on Monday, February 24th. Mizuho decreased their price target on shares of Synopsys from $650.00 to $600.00 and set an "outperform" rating for the company in a research note on Tuesday, April 15th. Needham & Company LLC reissued a "buy" rating and set a $650.00 target price on shares of Synopsys in a research report on Thursday. KeyCorp set a $575.00 price objective on Synopsys and gave the stock an "overweight" rating in a report on Tuesday, May 20th. Finally, Wells Fargo & Company dropped their price objective on shares of Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research note on Thursday, February 27th. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to MarketBeat, Synopsys has a consensus rating of "Moderate Buy" and a consensus price target of $609.64.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.